Clostridium Difficile
3 competing products in clinical development for Clostridium Difficile.
Pipeline by Phase
Phase 31
Approved2
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Fidaxomicin + Vancomycin | Astellas Pharma | Approved | Completed | 43 |
| OPT-80 + vancomycin | Astellas Pharma | Phase 3 | Completed | 40 |
| Fidaxomicin + Vancomycin + Placebo | Astellas Pharma | Approved | Terminated | 35 |